Skip to main content

College of Pharmacy

College of Pharmacy

Faculty Profile

Taryn EubankTaryn A. Eubank

Research Assistant Professor
Pharmacy Practice and Translational Research

Office: 
University of Houston College of Pharmacy
Health 2, Room 4039
4349 Martin Luther King Boulevard
Houston, TX 77204-5039

Contact: taeubank@Central.UH.EDU - 832-842-4040

Research:

Dr. Eubank's research interests are centered on antimicrobial resistance, gut microbiome and gut resistome, and Clostridioides difficile.

  • B.S. in Biochemistry and Molecular Biology, Cum Laude, 2011-15, Harding University, Searcy, Ark.
  • Pharm.D., Magna Cum Laude, 2015-19, Harding University, Searcy, Ark.
  • PGY1 Pharmacy Practice Resident, 2019-20, Houston Methodist Hospital, Houston, TX
  • PGY2 Infectious Diseases Resident, 2020-21, Houston Methodist Hospital, Houston, TX
  • Fellow, Infectious Diseases Research, 2021-23, University of Houston College of Pharmacy, Houston, TX
Google Scholar Profile
  • Salazar E, Perez KK, Ashraf M, Chen J, Castillo B, Christensen PA, Eubank TA, Bernard DW, Eagar TN, Long SW, Subedi S, Olsen RJ, Leveque C, Schwartz MR, Dey M, Chavez-East C, Rogers J, Shehabeldin A, Joseph D, Williams G, Thomas K, Masud F, Talley C, Dlouhy KG, Lopez BV, Hampton C, Lavinder J, Gollihar JD, Maranhao AC, Ippolito GC, Saavedra MO, Cantu CC, Yerramilli P, Pruitt L, Musser JM. Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma. Am J Pathol. 2020 Aug;190(8):1680-1690. doi: 10.1016/j.ajpath.2020.05.014. Epub 2020 May 27. PMID: 32473109; PMCID: PMC7251400.
  • Wolfe CR, Tomashek KM, Patterson TF, Eubank TA - ACTT-4 Study Group. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial. Lancet Respir Med. 2022;10(9):888-899. doi:10.1016/S2213-2600(22)00088-1
  • Gonzales-Luna AJ, Dureja C, Eubank TA, Garey KW, Hurdle JG. Surveillance of Clostridioides difficile Antimicrobial Resistance in the United States. Clinical Infectious Diseases. Published online 2023. doi:10.1101/2022.09.23.509282
  • Steere EL, Eubank TA, Cooper MH, Greenlee SB, Drake TC. Impact of Hypoalbuminemia on Ceftriaxone Treatment Failure in Patients With Enterobacterales Bacteremia: A Propensity-Matched, Retrospective Cohort Study. Open Forum Infect Dis. 2023;10(3). doi:10.1093/ofid/ofad102
  • Eubank, TA; Hu, C.; Gonzales-Luna, AJ; Garey, KW Detectable Vancomycin Stool Concentrations in Hospitalized Patients with Diarrhea Given Intravenous Vancomycin. Pharmacoepidemiology 2023, 2, 283-288. https://doi.org/10.3390/pharma2040024
  • Eubank TA, Long SW, Perez KK. Role of Rapid Diagnostics in Diagnosis and Management of Patients with Sepsis. J Infect Dis. 2020 Jul 21;222:S103-S109. doi:10.1093/infdis/jiaa263
  • Eubank TA, Zaidan N, Alnezary FS, et al. Significant Publications on Infectious Diseases Pharmacotherapy in 2020. J Pharm Pract. Published online April 1, 2021. doi:10.1177/08971900211040438
  • Eubank TA, Mobley CM, Moaddab M, et al. Successful Treatment of Invasive Mucormycosis in Orthotopic Liver Transplant Population. Case Rep Transplant. 2021;2021:1-7. doi:10.1155/2021/8667589
  • Eubank TA, Gonzales-Luna AJ, Hurdle JG, Garey KW. Genetic Mechanisms of Vancomycin Resistance in Clostridioides difficile: A Systematic Review. Antibiotics (Basel). 2022 Feb 16;11(2):258. doi: 10.3390/antibiotics11020258.PMID: 35203860
  • Presentation: Outpatient therapies for COVID-19. ASM-Microbe Conference. Houston, TX. June 17th, 2023

Awards & Honors

  • Inducted member to Pharmacy Leadership Society (Phi Lambda Sigma), 2021
  • Houston Methodist Humanitas Award Recipient, 2021
  • Board Certified Infectious Diseases Pharmacist (BCIDP), Board of Pharmacy Specialties, 2021